Sciomics GmbH
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Diagnostics
- Medical device or technology
- Other R&D services
Robust immuno-based proteomics for pre-clinical research and biomarker development. Explore our service portfolio for protein profiling and post-translational modification status screening. In addition, we are looking for strategic partners to advance precision medicine via an in-house pipeline of robust protein biomarker panels with a focus on AKI and ecology.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}